Medical Imaging Department, Institut Bergonié, Bordeaux, France.
Department of Biopathology, Institut Bergonié, Bordeaux, France.
Histopathology. 2019 Dec;75(6):900-915. doi: 10.1111/his.13950. Epub 2019 Oct 18.
The diagnosis of radial scars/complex sclerosing lesions (RSs/CSLs) onpercutaneous biopsy carries a risk of histological underestimation. Consequently, surgical excision is often performed in order to exclude a possible associated malignancy. The aim of this study was to assess the rate of 'upgrade to carcinoma' upon subsequent surgical excision of RS/CSL cases diagnosed on vacuum-assisted large-core biopsy (VALCB). We also analysed the risk factors for upgrade in order to determine a subset of patients who could avoid surgery and benefit from conservative management with clinical and imaging follow-up.
This was a retrospective observational single-centre study on 174 consecutive RS/CSL cases diagnosed on VALCB from May 2008 to October 2015. Univariate analysis was performed to identify clinical, radiological and histological risk factors for upgrade. Surgical excision was performed following VALCB diagnosis of 88 RS/CSL cases with or without associated atypia. The overall rate of surgical upgrade to carcinoma was 9.1% (8/88). None of the benign biopsies without atypia was surgically upgraded. Additional to atypia, risk factors for upgrade were non-incidental finding of the RS/CSL, the mammographic appearance, and the number of fragments obtained during the biopsy procedure (P < 0.05).
We demonstrate that VALCB revealing an RS/CSL is reliable for excluding malignancy when there is no associated atypia and when radiological and histological findings are concordant. In such cases, surgery can be avoided in favour of clinical and imaging follow-up. When an RS/CSL is associated with atypia, the decision to perform surgical excision depends on other associated risk factors.
经皮穿刺活检诊断的放射状瘢痕/复杂硬化性病变(RS/CSLs)存在组织学低估的风险。因此,为了排除可能的相关恶性肿瘤,通常会进行手术切除。本研究旨在评估经真空辅助大芯活检(VALCB)诊断的 RS/CSL 病例在随后的手术切除中“升级为癌”的发生率。我们还分析了升级的危险因素,以确定一组可以避免手术并通过临床和影像学随访进行保守管理的患者。
这是一项回顾性观察性单中心研究,纳入了 2008 年 5 月至 2015 年 10 月期间经 VALCB 诊断的 174 例连续 RS/CSL 病例。进行单因素分析以确定升级的临床、影像学和组织学危险因素。在 VALCB 诊断后,对 88 例具有或不具有相关不典型性的 RS/CSL 病例进行了手术切除。总的手术升级为癌的发生率为 9.1%(8/88)。没有不典型性的良性活检均未进行手术升级。除了不典型性外,升级的危险因素还包括偶然发现 RS/CSL、乳腺 X 线表现以及活检过程中获得的碎片数量(P<0.05)。
我们证明,当没有相关不典型性且影像学和组织学表现一致时,VALCB 显示 RS/CSL 可可靠地排除恶性肿瘤。在这种情况下,可以避免手术,转而进行临床和影像学随访。当 RS/CSL 伴有不典型性时,是否进行手术切除取决于其他相关危险因素。